SummaryBackground Delirium is a common, but potentially preventable complication of acute illness that is associated with important adverse outcomes including increased length of hospital admission, risk of dementia and admission to long-term care. In-hospital risk assessment and diagnosis Age over 65,...
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-1687. doi:10.1093/cvr/cvaa106PubMedGoogle Scholar 21. Lu CC, Chen MY, Lee WS, Chang YL. Potential therapeutic agents against CO...
Background Hospital‐acquired venous thromboembolism (HA VTE) is a preventable complication in hospitalized patients. Objective We aimed to examine the use of pharmacologic prophylaxis (pPPX) and compare two risk assessment methods for HA VTE: a retrospective electronic Padua Score (ePaduaKP) and adm...
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open. 2023;6(3):e232338. doi:10.1001/jamanetworkopen.2023.2338 2) Waljee AK, Rogers MA, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the ...
Risk assessmentInpatientsAcademic medical centersHighlights Few academic hospitalists use valid models to assess thrombosis or bleeding risk. Most academic hospitalists informally assess thrombosis and bleeding risk. When formally assessing risk, locally developed tools are commonly used....
D. et al. Global alcohol exposure estimates by country, territory and region for 2005—a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction 108, 912–922 (2013). Article PubMed Google Scholar Poznyak, V. et al. The world health ...
Medication use and fall‐risk assessment for falls in an acute care hospital A nested case–control study was carried out to examine relationships of a fall‐risk score and the use of single medications and polypharmacy with falls among hospitalized patients aged 50 years and older in Taiwan. M...
If an unacceptable increase in cardiovascular risk was not discharged at the interim analysis, the SURPASS-4 trial was to continue until accrual of 133 participants with MACE-4 occurred. In this setting, the primary cardiovascular risk assessment of tirzepatide was to be the analysis conducted ...
Therefore, this model enhances, not replaces, physician assessment. Moreover, because the ADHERE registry does not contain specific patient identifiers, information regarding patient status following hospital discharge is not available. Thus the effects of any of the variables evaluated in this analysis...
Support risk management processes with free, customizable risk planning templates. Includes a risk register, risk assessment matrix, RBS template.